Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Cancer Gene Ther ; 22(9): 454-62, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26337747

ABSTRACT

We have investigated if immunotherapy against human papilloma virus (HPV) using a viral gene delivery platform to immunize against HPV 16 genes E6 and E7 (Ad5 [E1-, E2b-]-E6/E7) combined with programmed death-ligand 1 (PD-1) blockade could increase therapeutic effect as compared to the vaccine alone. Ad5 [E1-, E2b-]-E6/E7 as a single agent induced HPV-E6/E7 cell-mediated immunity. Immunotherapy using Ad5 [E1-, E2b-]-E6/E7 resulted in clearance of small tumors and an overall survival benefit in mice with larger established tumors. When immunotherapy was combined with immune checkpoint blockade, an increased level of anti-tumor activity against large tumors was observed. Analysis of the tumor microenvironment in Ad5 [E1-, E2b-]-E6/E7 treated mice revealed elevated CD8(+) tumor infiltrating lymphocytes (TILs); however, we observed induction of suppressive mechanisms such as programmed death-ligand 1 (PD-L1) expression on tumor cells and an increase in PD-1(+) TILs. When Ad5 [E1-, E2b-]-E6/E7 immunotherapy was combined with anti-PD-1 antibody, we observed CD8(+) TILs at the same level but a reduction in tumor PD-L1 expression on tumor cells and reduced PD-1(+) TILs providing a mechanism by which combination therapy favors a tumor clearance state and a rationale for pairing antigen-specific vaccines with checkpoint inhibitors in future clinical trials.


Subject(s)
B7-H1 Antigen/biosynthesis , Cancer Vaccines/therapeutic use , Immunotherapy , Oncogene Proteins, Viral/immunology , Papillomaviridae/immunology , Papillomavirus E7 Proteins/immunology , Repressor Proteins/immunology , Tumor Virus Infections/therapy , Uterine Cervical Neoplasms/therapy , Animals , Apoptosis/genetics , B7-H1 Antigen/antagonists & inhibitors , B7-H1 Antigen/genetics , Cell Line, Tumor , Combined Modality Therapy , Defective Viruses/genetics , Defective Viruses/immunology , Female , Gene Expression Regulation , Humans , Immunoglobulin G/immunology , Lymphocyte Count , Lymphocytes, Tumor-Infiltrating/immunology , Mice , Mice, Inbred C57BL , Oncogene Proteins, Viral/genetics , Papillomaviridae/genetics , Papillomavirus E7 Proteins/genetics , Rats , Repressor Proteins/genetics , T-Lymphocytes, Cytotoxic/immunology , Tumor Microenvironment , Tumor Virus Infections/pathology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Xenograft Model Antitumor Assays
2.
Biochemistry ; 40(14): 4398-406, 2001 Apr 10.
Article in English | MEDLINE | ID: mdl-11284696

ABSTRACT

Dual-specificity phosphatase MKP3 down-regulates mitogenic signaling through dephosphorylation of extracellular regulated kinase (ERK). Unlike a simple substrate-enzyme interaction, the noncatalytic, amino-terminal domain of MKP3 can bind efficiently to ERK, leading to activation of the phosphatase catalytic domain by as much as 100-fold toward exogenous substrates. It has been suggested that ERK activates MKP3 through the stabilization of the active phosphatase conformation, enabling general acid catalysis. Here, we investigated whether Asp-262 of MKP3 is the bona fide general acid and evaluated its contribution to the catalytic steps activated by ERK. Using site-directed mutagenesis, pH rate and Brönsted analyses, kinetic isotope effects, and steady-state and rapid reaction kinetics, Asp-262 was identified as the authentic general acid catalyst, donating a proton to the leaving group oxygen during P-O bond cleavage. Kinetic isotope effects [(18)(V/K)(bridge), (18)(V/K)(nonbridge), and (15)(V/K)] were evaluated for the effect of ERK and of the D262N mutation on the transition state of the phosphoryl transfer reaction. The patterns of the three isotope effects for the reaction with native MKP3 in the presence of ERK are indicative of a reaction where the leaving group is protonated in the transition state, whereas in the D262N mutant, the leaving group departs as the anion. Even without general acid catalysis, the D262N mutant reaction is activated by ERK through increased phosphate affinity ( approximately 8-fold) and the partial stabilization of the transition state for phospho-enzyme intermediate formation ( approximately 4-fold). Based on these analyses, we estimate that dephosphorylation of phosphorylated ERK by the D262N mutant is >1000-fold lower than by native, activated MKP3. Also, the kinetic results suggest that Asp-262 functions as a general base during thiol-phosphate intermediate hydrolysis.


Subject(s)
Aspartic Acid/metabolism , Mitogen-Activated Protein Kinases/metabolism , Protein Tyrosine Phosphatases/metabolism , Amino Acid Substitution/genetics , Asparagine/genetics , Aspartic Acid/genetics , Binding Sites/genetics , Catalysis , Dual Specificity Phosphatase 3 , Dual Specificity Phosphatase 6 , Enzyme Activation/genetics , Hydrogen-Ion Concentration , Kinetics , Mutagenesis, Site-Directed , Nitrogen , Nitrogen Isotopes , Nitrophenols/metabolism , Organophosphorus Compounds/metabolism , Oxygen Isotopes , Phosphorylation , Protein Tyrosine Phosphatases/genetics , Substrate Specificity/genetics
3.
J Biol Chem ; 275(10): 6749-57, 2000 Mar 10.
Article in English | MEDLINE | ID: mdl-10702230

ABSTRACT

The dual specificity mitogen-activated protein kinase phosphatase MKP3 has been shown to down-regulate mitogenic signaling through dephosphorylation of extracellular signal-regulated kinase (ERK). Camps et al. (Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998) Science 280, 1262-1265) had demonstrated that ERK binding to the noncatalytic amino-terminal domain of MKP3 can dramatically activate the phosphatase catalytic domain. The physical basis for this activation has not been established. Here, we provide detailed biochemical evidence that ERK activates MKP3 through the stabilization of the active phosphatase conformation, inducing closure of the catalytic "general acid" loop. In the closed conformation, this loop structure can participate efficiently in general acid/base catalysis, substrate binding, and transition-state stabilization. The pH activity profiles of ERK-activated MKP3 clearly indicated the involvement of general acid catalysis, a hallmark of protein-tyrosine phosphatase catalysis. In contrast, unactivated MKP3 did not display this enzymatic group as critical for the low activity form of the enzyme. Using a combination of Brönsted analyses, pre-steady-state and steady-state kinetics, we have isolated all catalytic steps in the reaction and have quantified the specific rate enhancement. Through protonation of the leaving group and transition-state stabilization, activated MKP3 catalyzes formation of the phosphoenzyme intermediate approximately 100-fold faster than unactivated enzyme. In addition, ERK-activated MKP3 catalyzes intermediate hydrolysis 5-6-fold more efficiently and binds ligands up to 19-fold more tightly. Consistent with ERK stabilizing the active conformation of MKP3, the chemical chaperone dimethyl sulfoxide was able to mimic this activation. A general protein-tyrosine phosphatase regulatory mechanism involving the flexible general acid loop is discussed.


Subject(s)
Mitogen-Activated Protein Kinase 1/pharmacology , Mitogen-Activated Protein Kinases/pharmacology , Protein Tyrosine Phosphatases/metabolism , Catalysis , Dimethyl Sulfoxide/pharmacology , Dual Specificity Phosphatase 6 , Enzyme Activation , Hydrogen-Ion Concentration , Kinetics , Mitogen-Activated Protein Kinase 3 , Protein Tyrosine Phosphatases/chemistry
4.
Meat Sci ; 30(1): 1-12, 1991.
Article in English | MEDLINE | ID: mdl-22061646

ABSTRACT

Tensile tests were carried out on ribbons of perimysial connective tissue dissected from slices of bovine semitendinosus muscles that had been conditioned or not conditioned and then cooked to a range of temperatures. A consistent reduction in the strength of the perimysia was seen in the conditioned samples, both in the raw meat and meat cooked to 50°C. At higher cooking temperatures (60-80°C), no effect of conditioning was seen. The content of collagen or total protein of mechanically extracted perimysia and the collagen content of the test pieces from conditioned and unconditioned muscles was not significantly different. It was concluded that conditioning decreases the breaking strength of the perimysial connective tissue in raw meat or in meat which is subsequently cooked to 50°C, but not in meat cooked to the temperatures normally employed by consumers. The tenderization observed in conditioned meat cooked to 60°C and above is, therefore, due to the weakening of muscle fibres within the fibre bundles.

SELECTION OF CITATIONS
SEARCH DETAIL